Managing side effects of JAK inhibitors for myelofibrosis in clinical practice

Saeed, I; McLornan, D; Harrison, CN

Harrison, CN (reprint author), Guys & St Thomas NHS Fdn, Dept Haematol, London SE1 9RT, England.

EXPERT REVIEW OF HEMATOLOGY, 2017; 10 (7): 617

Abstract

Introduction: Myelofibrosis (MF) is characterized by bone marrow fibrosis, abnormalities in peripheral counts, extramedullary hematopoiesis, splenomeg......

Full Text Link